FMRI-neurofeedback in Parkinson's Disease
RecruitingNCT06582355Phase: NAStarted 2025-02-10
Summary
Rationale: Current treatment of patients with Parkinson's disease (PD) is mainly based on the modulation of neural activity in the motor circuits of the basal ganglia and cerebral cortex by either dru
Eligibility
Sex
ALL
Min Age
18 Years
Max Age
None
Locations
Uniklinik KölnCologne, Germany
Maastricht UniversityMaastricht, Netherlands
View full study details on ClinicalTrials.gov
clinicaltrials.gov/study/NCT06582355